Grindeks AS operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other
pharmaceutical manufacturers in Europe:
Dottikon ES Holding AG
sales of 151.75 million Swiss Francs [US$157.09 million]
of which 89%
was Pharma Products),
Opus Global Nyrt
(42.59 billion Hungarian Forints [US$169.52 million]
(122.08 million Euro [US$151.09 million]
During the year ended December of 2017, sales at
Grindeks AS were 132.41 million Euro (US$163.87 million).
increase of 25.7%
versus 2016, when the company's sales were 105.37 million Euro.